AMRX vs AWK
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) versus American Water Works (AWK) — a side-by-side from cached financials, not a winner call.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Latest reported AMRX revenue for 2024-12-31 was $2.79B. Net income was -$73.9M. Revenue was up 16.7% from 2023-12-31 to 2024-12-31. AMRX currently screens at market cap $5.19B and trailing P/E 44.0.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
AMRX currently screens at market cap $5.19B and trailing P/E 44.0. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Not investment advice. Open the AMRX and AWK stock pages for the full models.
Not investment advice.